Caption Genna Douglas photographed by Paul Meyler We’re partnering with Next to get Parkinson’s understood Date 29 March 2021 Genna, 39, has Parkinson’s. She’s designed an exclusive range of T-shirts and bags for Next. This new partnership will help more people understand Parkinson’s and raise vital funds to support others with the condition.
Luke and Blake re-release their 1967 single "Big Day" for Parkinson's UK Date 17 March 2021 "Big Day", written by David Capri in 1967 as part of the sixties duo Luke and Blake, has been re-released with the support of broadcasting legend David ‘Kid’ Jensen to raise vital funds for Parkinson’s UK.
Lockdown's impact on speech and language therapy Date 16 March 2021 The latest report by the Royal College of Speech and Language Therapists shows the impact of lockdown on this vital therapy.
Scientists move closer to developing ‘game-changing’ test to diagnose Parkinson’s Date 10 March 2021 Research shows it’s possible to identify Parkinson’s based on compounds found on the surface of skin. The findings offer hope that the condition could be diagnosed through a simple swab test.
We're investing £1.2m into drug that could slow Parkinson's Date 9 March 2021 We’re investing up to £1.2m into pioneering research in partnership with the University of Sheffield, which aims to develop a drug to protect dopamine-producing brain cells.
Our chair Gary Shaughnessy looks ahead to 2021 Date 24 February 2021 In 2020, coronavirus (COVID-19) brought normal life to a standstill. But the Parkinson’s community showed its resilience as people found innovative ways to support each other.
Caption Christine Proctor - participant in the GDNF trial Why we’re committing £800,000 to plan a new GDNF trial Date 23 February 2021 The earlier groundbreaking clinical trial proved inconclusive. So we’re launching a new company tasked with planning a possible new trial.
Parkinson’s ambassador David Jensen joins Jazz FM Date 18 February 2021 The broadcasting legend will front a new 6-part jazz series, which will also highlight the work of Parkinson’s UK.
Further clues about alpha-synuclein Date 11 February 2021 New research has advanced our understanding of a protein called alpha-synuclein, which is believed to play a central role in damaging brain cells in Parkinson’s.
Shan Nicholas joins the team as Interim Chief Executive Date 20 January 2021 As Steve Ford prepares to step down, Shān brings extensive leadership experience from across the charity sector to Parkinson’s UK.
